The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis
Open accessAbstract
Congenital neuronal ceroid-lipofuscinosis (NCL) is a devastating inherited neurodegenerative disorder of unknown metabolic basis. Eight patients with this rare disorder, all with similar clinical and neuropathological findings, have been reported, and here we describe two further patients. Previously, we showed that a mutation in the cathepsin D gene causes congenital NCL in sheep. On the basis of the neuropathological and ultrastructural similarities between the sheep and patients affected with congenital NCL, we screened the cathepsin D gene for mutations in a patient of Pakistani origin. We identified a nucleotide duplication, c.764dupA, in the cathepsin D gene in homozygous form in the patient, and in heterozygous form in his father. This duplication is likely to be disease-causing, as it creates a premature stop codon, predicting a truncation of the protein. When transiently expressed in cell cultures, the mutant protein was enzymatically inactive, but stable. In paraffin-embedded brain tissue samples of two affected siblings of the Pakistani patient, cathepsin D was absent, suggesting rapid degradation of the c.764dupA mutant cathepsin D at mRNA or protein level in vivo. Further, we were able to confirm lack of cathepsin D in the brain tissue of yet another, unrelated, patient of English origin with congenital NCL. On the basis of the present data, and the nearly identical clinical and/or pathological phenotype of the other reported cases of congenital NCL, it is reasonable to suggest that cathepsin D deficiency caused by mutations in the corresponding gene may underlie all cases of congenital NCL. The present observations also suggest that cathepsin D deficiency should be considered as a possible diagnosis in microcephalic neonates, who present with seizures at or before birth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vesa, J., Hellsten, E., Verkruyse, L. A., Camp, L. A., Rapola, J., Santavuori, P., Hofmann, S. L., & Peltonen, L. (1995) · Nature · doi:10.1038/376584a0 · Cited by 737
Saftig, P., Hetman, M., Schmahl, W., Weber, K., Heine, L., Mossmann, H., Köster, A., Hess, B., Evers, M., & von Figura, K. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00029.x · Cited by 438
Cathepsin D Deficiency Induces Lysosomal Storage with Ceroid Lipofuscin in Mouse CNS Neurons
Koike, M., Nakanishi, H., Saftig, P., Ezaki, J., Isahara, K., Ohsawa, Y., Schulz-Schaeffer, W., Watanabe, T., Waguri, S., Kametaka, S., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-18-06898.2000 · Cited by 393
The Neuronal Ceroid-Lipofuscinoses
Haltia, M. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.1.1 · Cited by 353
Cloning and sequence analysis of cDNA for human cathepsin D.
Faust, P. L., Kornfeld, S., & Chirgwin, J. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.15.4910 · Cited by 322
The isolation and properties of a proteolytic enzyme, cathepsin D, from bovine spleen
Press, E. M., Porter, R. R., & Cebra, J. (1960) · Biochemical Journal · doi:10.1042/bj0740501 · Cited by 265
Tyynelä, J., Sohar, I., Sleat, D. E., Gin, R. M., Donnelly, R. J., Baumann, M., Haltia, M., & Lobel, P. (2000) · The EMBO Journal · doi:10.1093/emboj/19.12.2786 · Cited by 245 · cited 18×
“Previously, an active site mutation (corresponding to human p.Asp295Asn) in the ovine cathepsin D (CTSD) gene was identified as a cause of congenital NCL in sheep (Tyynelä et al., 2000).”
BackgroundThe Neuronal Ceroid-Lipofuscinoses (Batten Disease)
Mole, S. E., & Haltia, M. (2015) · Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease · doi:10.1016/b978-0-12-410529-4.00070-x · Cited by 220
Passini, M. A., Dodge, J. C., Bu, J., Yang, W., Zhao, Q., Sondhi, D., Hackett, N. R., Kaminsky, S. M., Mao, Q., Shihabuddin, L. S., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2676-05.2006 · Cited by 172
[7] Families of aspartic peptidases, and those of unknown catalytic mechanism
Rawlings, N. D., & Barrett, A. J. (1995) · Methods in Enzymology · doi:10.1016/0076-6879(95)48009-9 · Cited by 168
Cited by
The role of autophagy in neurodegenerative disease
Nixon, R. A. (2013) · Nature Medicine · doi:10.1038/nm.3232 · Cited by 2,059
Pastores, G. M. (2012) · Swaiman's Pediatric Neurology · doi:10.1016/b978-1-4377-0435-8.00036-6 · Cited by 633
The molecular basis of human retinal and vitreoretinal diseases
Berger, W., Kloeckener-Gruissem, B., & Neidhardt, J. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.03.004 · Cited by 594
Cathepsin D--many functions of one aspartic protease
Benes, P., Vetvicka, V., & Fusek, M. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.02.008 · Cited by 572
The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management
Yadati, T., Houben, T., Bitorina, A., & Shiri-Sverdlov, R. (2020) · Cells · doi:10.3390/cells9071679 · Cited by 541
Autophagy in lysosomal storage disorders
Lieberman, A. P., Puertollano, R., Raben, N., Slaugenhaupt, S., Walkley, S. U., & Ballabio, A. (2012) · Autophagy · doi:10.4161/auto.19469 · Cited by 399
Neuronal ceroid lipofuscinoses
Jalanko, A., & Braulke, T. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.11.004 · Cited by 339
Lysosomal cathepsins and their regulation in aging and neurodegeneration
Stoka, V., Turk, V., & Turk, B. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.04.010 · Cited by 334
Kousi, M., Lehesjoki, A.-E., & Mole, S. E. (2012) · Human Mutation · doi:10.1002/humu.21624 · Cited by 332
Genetics of the neuronal ceroid lipofuscinoses (Batten disease)
Mole, S. E., & Cotman, S. L. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.05.011 · Cited by 331
Vassar, R., Kuhn, P., Haass, C., Kennedy, M. E., Rajendran, L., Wong, P. C., & Lichtenthaler, S. F. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12715 · Cited by 311
Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo
Cullen, V., Lindfors, M., Ng, J., Paetau, A., Swinton, E., Kolodziej, P., Boston, H., Saftig, P., Woulfe, J., Feany, M. B., et al. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-5 · Cited by 279
Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity
Qiao, L., Hamamichi, S., Caldwell, K. A., Caldwell, G. A., Yacoubian, T. A., Wilson, S., Xie, Z.-L., Speake, L. D., Parks, R., Crabtree, D., et al. (2008) · Molecular Brain · doi:10.1186/1756-6606-1-17 · Cited by 263
The evolving role of investigative toxicology in the pharmaceutical industry
Pognan, F., Beilmann, M., Boonen, H. C. M., Czich, A., Dear, G., Hewitt, P., Mow, T., Oinonen, T., Roth, A., Steger-Hartmann, T., et al. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00633-x · Cited by 255
NCL diseases - clinical perspectives
Schulz, A., Kohlschütter, A., Mink, J., Simonati, A., & Williams, R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.04.008 · Cited by 246
Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-βCTF (C99)
Jiang, Y., Sato, Y., Im, E., Berg, M., Bordi, M., Darji, S., Kumar, A., Mohan, P. S., Bandyopadhyay, U., Diaz, A., et al. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.0578-19.2019 · Cited by 166
The Role of Cathepsin D in the Pathogenesis of Human Neurodegenerative Disorders
Vidoni, C., Follo, C., Savino, M., Melone, M. A. B., & Isidoro, C. (2016) · Medicinal Research Reviews · doi:10.1002/med.21394 · Cited by 164
Endo‐lysosomal and autophagic dysfunction: a driving factor in Alzheimer's disease?
Whyte, L. S., Lau, A. A., Hemsley, K. M., Hopwood, J. J., & Sargeant, T. J. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13935 · Cited by 150
Progranulin functions as a cathepsin D chaperone to stimulate axonal outgrowth in vivo
Beel, S., Moisse, M., Damme, M., De Muynck, L., Robberecht, W., Van Den Bosch, L., Saftig, P., & Van Damme, P. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx162 · Cited by 146
Cathepsin F mutations cause Type B Kufs disease, an adult-onset neuronal ceroid lipofuscinosis
Smith, K. R., Dahl, H.-H. M., Canafoglia, L., Andermann, E., Damiano, J., Morbin, M., Bruni, A. C., Giaccone, G., Cossette, P., Saftig, P., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds558 · Cited by 130
Radke, J., Stenzel, W., & Goebel, H. H. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.05.007 · Cited by 122
Endosomal sorting and trafficking, the retromer complex and neurodegeneration
Vagnozzi, A. N., & Praticò, D. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0221-3 · Cited by 95
Lysosomal functions of progranulin and implications for treatment of frontotemporal dementia
Simon, M. J., Logan, T., DeVos, S. L., & Di Paolo, G. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.09.006 · Cited by 94
Chai, Y. L., Chong, J. R., Weng, J., Howlett, D., Halsey, A., Lee, J. H., Attems, J., Aarsland, D., Francis, P. T., Chen, C. P., et al. (2019) · Brain Pathology · doi:10.1111/bpa.12631 · Cited by 73
The propeptide of yeast cathepsin D inhibits programmed necrosis
Carmona-Gutiérrez, D., Bauer, M. A., Ring, J., Knauer, H., Eisenberg, T., Büttner, S., Ruckenstuhl, C., Reisenbichler, A., Magnes, C., Rechberger, G. N., et al. (2011) · Cell Death & Disease · doi:10.1038/cddis.2011.43 · Cited by 69
Moving towards a new era of genomics in the neuronal ceroid lipofuscinoses
Butz, E. S., Chandrachud, U., Mole, S. E., & Cotman, S. L. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165571 · Cited by 62
Cathepsin D in Podocytes Is Important in the Pathogenesis of Proteinuria and CKD
Yamamoto-Nonaka, K., Koike, M., Asanuma, K., Takagi, M., Oliva Trejo, J. A., Seki, T., Hidaka, T., Ichimura, K., Sakai, T., Tada, N., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015040366 · Cited by 59
Mustaly-Kalimi, S., Gallegos, W., Marr, R. A., Gilman-Sachs, A., Peterson, D. A., Sekler, I., & Stutzmann, G. E. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211999119 · Cited by 55
“5) and aligns with studies demonstrating inactivation of lysosomal hydrolytic enzymes, including cathepsin D,B,L, in neurodegenerative diseases (69, 70).”
BackgroundSystemic Diseases Associated with Retinal Dystrophies
Werdich, X. Q., Place, E. M., & Pierce, E. A. (2014) · Seminars in Ophthalmology · doi:10.3109/08820538.2014.959202 · Cited by 54
“ANCL is relatively rare, with an onset of symptoms in the fourth decade or later, with dementia and progressive motor dysfunction.49 Currently, there is no treatment available for NCLs. Early diagnosis may improve anticipatory care and remedial management of signs and symptoms, including seizures.49 This phenotypic cl…”
BackgroundInfluentialSampognaro, P. J., Arya, S., Knudsen, G. M., Gunderson, E. L., Sandoval-Perez, A., Hodul, M., Bowles, K., Craik, C. S., Jacobson, M. P., & Kao, A. W. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00621-8 · Cited by 35
Mutka, A., Haapanen, A., Käkelä, R., Lindfors, M., Wright, A. K., Inkinen, T., Hermansson, M., Rokka, A., Corthals, G., Jauhiainen, M., et al. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06440.x · Cited by 34
Self-citationCraiu, D., Dragostin, O., Dica, A., Hoffman-Zacharska, D., Gos, M., Bastian, A. E., Gherghiceanu, M., Rolfs, A., Nahavandi, N., Craiu, M., et al. (2015) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2014.07.008 · Cited by 31
Guo, D.-Z., Xiao, L., Liu, Y.-J., Shen, C., Lou, H.-F., Lv, Y., & Pan, S.-Y. (2018) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.291 · Cited by 25
Loss of melanoregulin (MREG) enhances cathepsin-D secretion by the retinal pigment epithelium
FROST, L. S., LOPES, V. S., STEFANO, F. P., BRAGIN, A., WILLIAMS, D. S., MITCHELL, C. H., & BOESZE-BATTAGLIA, K. (2013) · Visual Neuroscience · doi:10.1017/s0952523813000096 · Cited by 9
Metadata
- Authors
- Siintola, E.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-04-13
- Volume
- 129
- Issue
- 6
- Pages
- 1438-1445
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2145396101
- Cited by
- 389
- References
- 24
- FWCI
- 17.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.